Literature DB >> 3456223

The role of raw starches in the treatment of type I glycogenosis.

J B Sidbury, Y T Chen, C R Roe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456223

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  6 in total

1.  Oral cornstarch therapy: is persorption harmless?

Authors:  R Gitzelmann; M A Spycher
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

2.  Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride.

Authors:  Charles R Roe; Lawrence Sweetman; Diane S Roe; France David; Henri Brunengraber
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

3.  A novel starch for the treatment of glycogen storage diseases.

Authors:  K Bhattacharya; R C Orton; X Qi; H Mundy; D W Morley; M P Champion; S Eaton; R F Tester; P J Lee
Journal:  J Inherit Metab Dis       Date:  2007-05-19       Impact factor: 4.982

4.  Effects of cornstarch treatment in very young children with type I glycogen storage disease.

Authors:  M Hayde; K Widhalm
Journal:  Eur J Pediatr       Date:  1990-06       Impact factor: 3.183

5.  A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type Ia.

Authors:  Vaneisse C L Monteiro; Bibiana M de Oliveira; Bruna B Dos Santos; Fernanda Sperb-Ludwig; Lilia F Refosco; Tatiele Nalin; Terry G J Derks; Carolina F Moura de Souza; Ida V D Schwartz
Journal:  Orphanet J Rare Dis       Date:  2021-06-03       Impact factor: 4.123

Review 6.  The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.

Authors:  Anna Rita Cappello; Rosita Curcio; Rosamaria Lappano; Marcello Maggiolini; Vincenza Dolce
Journal:  Front Chem       Date:  2018-04-17       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.